0.84
price down icon3.56%   -0.0414
 
loading

Renovorx Inc Azioni (RNXT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
39.34%
2.476
1.777 2.983 3.375 3.261
Operating Income/Loss
39.34%
-2.476
-1.777 -2.983 -3.375 -3.261
Nonoperating Income/Loss
196.55%
1.40
-1.45 1.562 1.048 0.004
Income/Loss From Continuing Operations Before Tax
66.66%
-1.076
-3.227 -1.421 -2.327 -3.257
Income/Loss From Continuing Operations After Tax
66.66%
-1.076
-3.227 -1.421 -2.327 -3.257
Net Income/Loss
66.66%
-1.076
-3.227 -1.421 -2.327 -3.257
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,911%
14.95
0.1358 10.69 10.66 9.09
Diluted Average Shares
10,911%
14.95
0.1358 10.69 10.66 -0.7738
Basic Earnings Per Share
76.67%
-0.07
-0.30 -0.13 -0.22 -0.36
Diluted Earnings Per Share
76.67%
-0.07
-0.30 -0.13 -0.22 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$58.85
price down icon 1.24%
$65.63
price down icon 4.29%
$16.05
price down icon 9.68%
$29.93
price down icon 3.59%
$84.97
price down icon 4.72%
biotechnology ONC
$215.25
price down icon 7.42%
Capitalizzazione:     |  Volume (24 ore):